Company Filing History:
Years Active: 2012-2024
Areas of Expertise:
Title: **Innovative Contributions of Hongying Yun in Pharmaceutical Patents**
Introduction
Hongying Yun, based in Shanghai, China, is a prominent inventor with a notable portfolio of 44 patents. His work primarily focuses on innovative compounds aimed at addressing significant medical challenges, particularly in the fields of autoimmune diseases and viral infections.
Latest Patents
Among his latest patents, Hongying Yun has made remarkable strides with two key inventions. The first is centered around **Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds** for the treatment of autoimmune diseases. This invention relates to specific compounds of formula (I), wherein R to R, m, and n are described alongside their pharmaceutically acceptable salts, enantiomers, or diastereomers, as well as the compositions and methods of utilizing these compounds. The second significant patent involves **Aminocarbamoyl compounds** aimed at treating viral infections. Similar to the first, this invention details compounds of formula (I), with an emphasis on their acceptable salts and the compositions connected to their applications and methods.
Career Highlights
Hongying Yun currently serves as an inventor at Hoffmann-La Roche Inc., a leading pharmaceutical company known for its dedication to innovation in healthcare solutions. His contributions not only enhance the company’s research endeavors but also play a crucial role in advancing medical treatments worldwide.
Collaborations
Throughout his career, Hongying Yun has collaborated with esteemed colleagues, including Lisha Wang and Xiufang Zheng. These partnerships have fostered a rich environment for knowledge exchange and innovation, further amplifying the impact of their collective research efforts.
Conclusion
In summary, Hongying Yun's contributions to the field of pharmaceuticals through his patents exemplify his commitment to addressing critical health issues. His innovative compounds, along with his collaborative spirit, position him as a key figure in the pharmaceutical industry, paving the way for future advancements in treatment methodologies.